Compliance, treatment practices and blood pressure control: Community survey findings

Wagner, Edward H.; Truesdale, Richard A.; Warner, Jeanne T.

doi:10.1016/0021-9681(81)90014-x

Cited by 15 publications

(5 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Indeed, if the patient is doing well, all is well. Thus, for instance, in a strategy of "intelligent non-adherence" patients rightly conclude they may achieve the same therapeutic success while reducing the medication prescribed, a fact long acknowledged amongst people with hypertension 48,49 . Even recent AIDS treatment studies have shown that for some antiretroviral regimens there is no need for "almost perfect" adherence as early studies had suggested 50 .…”

Section: Addressing Adherence In the Clinical Context: Seeking Bettermentioning

confidence: 99%

“…For this reason, studies measuring adherence in the epidemiological context rarely use clinicians' opinions as a method of measurement. When used, it is only considered as part of composed scales of adherence (once it is recognized that the clinicians' assessments of their patients' adherence are strongly based on the clinical and laboratorial results) 49,50 .…”

Section: Addressing Adherence In the Clinical Context: Seeking Bettermentioning

confidence: 99%

See 1 more Smart Citation

Assessing patient adherence to chronic diseases treatment: differentiating between epidemiological and clinical approaches

Nemes

Helena

Caraciolo³

et al. 2009

Cad. Saúde Pública

View full text Add to dashboard Cite

This review discusses the concepts and methods for assessing patient adherence to treatment, as applied to both epidemiological and clinical approaches within real health care practices. For the epidemiological approach, the assessment must be as accurate as possible. Self-reported questionnaires are the most feasible option in most circumstances, but most demonstrate low sensitivity combined with high specificity. We suggest that self-reported outcomes, where feasible, can increase the sensitivity for non-adherence of these questionnaires. In the clinical approach an accurate distinction between adherents and non-adherents is less useful. For the health provider, it is more important to be aware of the particular situation that each patient is currently experiencing with his/her treatment. Self-reported questionnaires applied in clinical settings can help the health provider to form an objective opinion. In any event, the patient-provider dialogue is still the best approach to assess patient adherence as well as to deliver good care.

show abstract

Section: Addressing Adherence In the Clinical Context: Seeking Bettermentioning

confidence: 99%

Section: Addressing Adherence In the Clinical Context: Seeking Bettermentioning

confidence: 99%

Assessing patient adherence to chronic diseases treatment: differentiating between epidemiological and clinical approaches

Nemes

Helena

Caraciolo³

et al. 2009

Cad. Saúde Pública

View full text Add to dashboard Cite

show abstract

“…Ethnic differences in survival and, to a lesser extent, in quality of life may be associated with the extent to which patients adhere to treatment recommendations. Poor adherence has been shown to be the cause of poor disease control among patients with numerous chronic diseases, including cancer (Bonadonna & Valagussa, 1981; Coronary Drug Project Research Group, 1980; Lipid Research Clinics Program, 1984; Pizzo et al, 1983; Richardson et al, 1990; Sackett, Haynes, Gibson, & Johnson, 1976; Stanway, Lambie, & Johnson, 1985; Wagner, Truesdale, & Warner, 1981). Although the impact on quality of life may be less direct, better disease control is likely to lead to better quality of life.…”

Section: Ethnicity and Cancer Outcomes: An Organizational Frameworkmentioning

confidence: 99%

Ethnicity and cancer outcomes: Behavioral and psychosocial considerations.

Meyerowitz

Richardson²,

Hudson³

et al. 1998

Psychological Bulletin

114

View full text Add to dashboard Cite

Cancer has been the subject of thousands of behavioral and psychosocial studies. The literature has focused largely on non-Hispanic Whites, despite the fact that cancer outcomes vary by ethnicity. This article provides a review of those studies that do consider the relations between ethnicity and cancer-related adherence behaviors, survival, and quality of life. The authors propose a mediational framework that links ethnicity and cancer outcomes through socioeconomic status, knowledge and attitudes, and access to medical care. They use this framework to organize the literature and to develop recommendations for future research.

show abstract

“…Ethnic differences in survival and, to a lesser extent, in quality of life may be associated with the extent to which patients adhere to treatment recommendations. Poor adherence has been shown to be the cause of poor disease control among patients with numerous chronic diseases, including cancer (Bonadonna & Valagussa, 198 1;Coronary Drug Project Research Group, 1980;Lipid Research Clinics Program, 1984;Pizzo et al, 1983;Richardson et al, 1990;Sackett, Haynes, Gibson, & Johnson, 1976;Stanway, Lambie, & Johnson, 1985;Wagner, Truesdale, & Warner, 1981). Although the impact on quality of life may be less direct, better disease control is likely to lead to better quality of life.…”

Section: Ethnic Difserences In Adherence To Treatmentmentioning

confidence: 99%

Ethnicity and cancer outcomes: Behavioral and psychosocial considerations.

Meyerowitz¹,

Richardson²,

Hudson³

et al.

Cancer Patients and Their Families: Readings on Disease Course, Coping, and Psychological Interventions.

View full text Add to dashboard Cite

Cancer is the second leading cause of death in the United States (National Center for Health Statistics, 1993). The American Cancer Society estimates that one in three Americans alive today will be diagnosed with cancer at some point during their lives. With over 8 million Americans currently living with or surviving cancer (American Cancer Society, 1995), it clearly is a major public health concern.Although many studies examine behavioral and psychosocial factors relevant to how people survive cancer and the quality of that survival (e.g., see Holland & Rowland, 1989), the focus of this literature has been almost entirely on non-Hispanic Whites. The extent to which findings can be generalized beyond the majority population is unknown. This lack of information is particularly unfortunate in light of rapidly increasing ethnic diversity within the United States and the high cancer rates within some ethnic groups.Our goal in this review is threefold. First, we propose a framework to organize and summarize what is known about the links between ethnicity and two general cancer-related outcomes-adherence behaviors and responses to cancer and its treatments, including both survival and quality of life. Second, we consider socioeconomic, knowledge-attitudinal, and medical system-patient interaction variables that might mediate the relation between ethnicity and these outcomes. Finally, we identify gaps in the literature that may be especially useful to explore in future research. In each of these areas-outcomes, mediators, and recommendations-we draw on three distinct literatures from public health and psychology. Despite apparent connections, the literatures on screening-follow-up behaviors, survival, and quality of life-coping are not well integrated and are inconsistent in their coverage of issues related to ethnicity. Before presenting the framework, we discuss difficulties inherent in studying ethnicity in these literatures. Studying Ethnic Diversity and CancerThe 1990 U.S. Census describes the United States population of 249 million, using their labels, as 71.3% non-Hispanic White, 9.0% Hispanic, 12.1% Black, 2.9% Asian/ Pacific Islander, 0.8% Native American, and 4.0% "other race." Between 1980 and 1990, the Asiaoacific Islander population increased by 108%, the Hispanic population by 53%, the Native American population by 38%, the Black population by 13%, and the non-Hispanic White population by only about 7% (U.S. Bureau of the Census, 1990a). Notwithstanding that there may have been an undercount of various

show abstract

Compliance, treatment practices and blood pressure control: Community survey findings

Cited by 15 publications

References 10 publications

Assessing patient adherence to chronic diseases treatment: differentiating between epidemiological and clinical approaches

Assessing patient adherence to chronic diseases treatment: differentiating between epidemiological and clinical approaches

Ethnicity and cancer outcomes: Behavioral and psychosocial considerations.

Ethnicity and cancer outcomes: Behavioral and psychosocial considerations.

Contact Info

Product

Resources

About